Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin.

Trial Profile

Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Oxaliplatin (Primary)
  • Indications Biliary cancer; Colorectal cancer; Gastric cancer; Oesophageal cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by
    • 17 Feb 2012 Planned End Date changed from 1 Nov 2011 to 1 Nov 2012 as reported by
    • 15 Feb 2011 Planned end date changed from 1 Jan 2011 to 1 Nov 2011 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top